Related Experiment Video
Updated: Jan 7, 2026

Detection of Anti-MDA5 Autoantibodies Using HeLa Cells and Immunocytochemistry with Light Microscopy
Published on: October 31, 2025
A Case of Anti-3-Hydroxy-Methylglutaryl-Coenzyme a Reductase (Anti-HMGCR) Immune-Mediated Necrotizing Myopathy
Jennifer S George1, Sahil Sabharwal1, Robert Donnell2
1Internal Medicine, University of Arkansas for Medical Sciences, Fayetteville, USA.
Abstract:
Anti-3-hydroxy-methylglutaryl-coenzyme A reductase (Anti-HMGCR) immune-mediated necrotizing myopathy (INMN) is a type of autoimmune myopathy that is commonly associated with a history of statin use. In this case report, we present a 47-year-old man with a history of statin use who was admitted to the hospital with elevated creatine kinase and progressive muscle weakness. Muscle biopsy and myositis panel confirmed the diagnosis of anti-HMGCR IMNM. Creatine kinase levels and symptoms improved with the initiation of glucocorticoids, mycophenolate mofetil, and rituximab. This case report expresses the need for continued research into the treatment guidelines as well as the long-term effects of anti-HMGCR IMNM.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
Myocarditis III: Medical Management
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
